You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Istari

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Malignant Glioma Trial (PVSRIPO, Atezolizumab)

Withdrawn
  • Malignant Glioma
  • (no location specified)
Feb 7, 2020

Melanoma Trial in Durham (PVSRIPO, Nivolumab)

Withdrawn
  • Melanoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2020

Glioblastoma Trial in Durham (PVSRIPO)

No longer available
  • Glioblastoma
  • PVSRIPO
  • Durham, North Carolina
    Duke University Medical Center
Jun 23, 2022

Malignant Glioma Trial in United States (PVSRIPO)

Active, not recruiting
  • Malignant Glioma
  • PVSRIPO
  • San Francisco, California
  • +5 more
Jun 28, 2022

Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • lerapolturev
  • pembrolizumab
  • San Francisco, California
  • +9 more
Nov 30, 2021

Invasive Breast Cancer Trial in Durham (PVSRIPO)

Recruiting
  • Invasive Breast Cancer
  • PVSRIPO
  • Durham, North Carolina
    Duke University Medical Center
Aug 4, 2021

GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

Completed
Has Results
  • GBM
  • +3 more
  • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
Jun 28, 2022